[Wegener's granulomatosis in childhood]. 2003

Brigita Puteliene, and Vilte Aleksyniene, and Jūrate Kasparaviciene
Clinic of Children's Diseases, Kaunas University of Medicine, Lithuania.

Our aim is to elucidate the rare case of Wegener granulomatosis in childhood: its clinical symptoms, treatment, complications and outcome. We present clinical case of 12-year-old boy with affection of airways, kidneys, skin, joints and eyes. Diagnosis was confirmed on the basis of clinical picture, laboratory findings and ultrasound, x-ray, computed tomography, magnetic resonance imaging and biopsies of skin, nasal mucosa, renal tissues. We found four of five positive modified American College of Rheumatology diagnostic criteria. Conventional treatment with corticosteroids and cyclophosphamide eliminated renal symptoms, but the damage of the upper and central airways increased with development of subglottic stenosis. This complication was treated by urgent tracheostomy. Remission of disease was achieved with maximal doses of corticosteroids ant cyclophosphamide during 13 months from of symptoms onset. Peculiarities of our case were early onset, rapid development of life threatening symptoms, treatment with large doses of drugs and urgent surgery. Aforementioned active treatment did not prevent complications - steroid side effects, infections, bone fracture and subglottic stenosis.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014140 Tracheotomy Surgical incision of the trachea. Tracheotomies

Related Publications

Brigita Puteliene, and Vilte Aleksyniene, and Jūrate Kasparaviciene
January 1991, Pediatric radiology,
Brigita Puteliene, and Vilte Aleksyniene, and Jūrate Kasparaviciene
January 1971, Acta paediatrica Academiae Scientiarum Hungaricae,
Brigita Puteliene, and Vilte Aleksyniene, and Jūrate Kasparaviciene
November 1971, Orvosi hetilap,
Brigita Puteliene, and Vilte Aleksyniene, and Jūrate Kasparaviciene
January 2014, Pediatric rheumatology online journal,
Brigita Puteliene, and Vilte Aleksyniene, and Jūrate Kasparaviciene
March 2012, Arthritis care & research,
Brigita Puteliene, and Vilte Aleksyniene, and Jūrate Kasparaviciene
September 1961, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Brigita Puteliene, and Vilte Aleksyniene, and Jūrate Kasparaviciene
December 1969, Archivos de oftalmologia de Buenos Aires,
Brigita Puteliene, and Vilte Aleksyniene, and Jūrate Kasparaviciene
December 1981, Klinicheskaia meditsina,
Brigita Puteliene, and Vilte Aleksyniene, and Jūrate Kasparaviciene
September 1992, Neurology,
Brigita Puteliene, and Vilte Aleksyniene, and Jūrate Kasparaviciene
September 1963, The Journal of laryngology and otology,
Copied contents to your clipboard!